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transmission in neurones (Klishin et al., 1994; Fröhlich et al., 1996) . It has been demonstrated that rat midbrain synaptic terminals respond to the addition of ATP and Ap n A with an increase in the intrasynaptosomal calcium concentration (Pintor y Miras-Portugal, 1995) . The effect of ATP was mediated through P2X receptors with P2X 3 -like pharmacology . However, Ap n A effect appeared to be mediated through different receptors, termed dinucleotide receptors, which are activated by dinucleotide polyphosphates but not by ATP or UTP. These receptors are insensitive to classical P2 antagonists such as PPADS and suramin and can be selectively inhibited by nanomolar concentrations of diinosine pentaphosphate (Pintor et al., 1997a) . The existence of dinucleotide receptors has been reported in rat, guinea pig and deermouse synaptosomes (reviewed by Pintor et al., 2000) . Moreover, the Ca 2+ signalling mediated by dinucleotide receptors is regulated by the action of protein kinases and phosphatases, and effectors increasing PKA or PKC activity result in a considerable reduction of the calcium response (Pintor et al, 1997b; Díaz-Hernández et al., 2000) . The regulation of dinucleotide receptors by presynaptic G-protein coupled adenosine receptors, one of the most important regulators of synaptic transmission, has also been described. Thus, adenosine activating A 1 or A 2A receptors potentiates Ap 5 A calcium responses in rat brain synaptic terminals Díaz-Hernández et al., 2002a) .
Considering that dinucleotide receptors are receptor operated calcium channels, they might be involved in facilitatory presynaptic mechanisms in central neurones. In this way, the dinucleotide receptor activation induces the release of excitatory neurotransmitters such as acetylcholine or glutamate from cholinergic and glutamatergic synaptic terminals, This article has not been copyedited and formatted. The final version may differ from this version. respectively (Díaz-Hernández et al., 2002b . It is to notice that Ap n A are also able to evoke γ-aminobutyric acid (GABA) release from GABAergic terminals . This fact together with the results reported previously by other groups suggests a close relationship between GABAergic and purinergic neurotransmitter systems in the CNS (Jo and Schlichter, 1999, Inoue et al., 1999; Hugel and Schlichter, 2000) .
In the brain of vertebrates, GABA is the main inhibitory neurotransmitter, being able to activate two different mechanisms: one ionotropic, GABA A receptors, and other metabotropic, G-coupled GABA B receptors. Presynaptic GABA B receptors are widely distributed on brain nerve terminals where they act mediating the inhibition of neurotransmitter release by direct inhibition of voltage-dependent calcium channels. This effect is inhibited by pertussis toxin, indicating the involvement of a G i /G 0 -protein-coupled receptor. Additionally, GABA B receptor activation has been associated with the opening of inwardly rectifying K + channels (GIRKs) and the modulation of adenylyl cyclase (AC) (Wu and Saggau, 1997; Filippov et al., 2000; Billinton et al., 2001) . Keeping in view that diadenosine polyphosphates are able to induce GABA release form nerve terminals and, consequently, both transmitters can co-exist extracellularly in synaptosomal preparations, the aim of this work was to analyse the effect of presynaptic GABA receptor activation on the Ca 2+ responses elicited by Ap 5 A in rat synaptic terminals.
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Methods

Chemicals
Ap 5 A, baclofen, bovine serum albumin (BSA), GABA, Gp 5 G, muscimol, paraformaldehyde (PFA), saclofen, mouse anti-synaptophysin, rabbit anti-GABA A receptor α3 subunit, guinea-pig anti-GABA B R1 receptor, rabbit anti-glial fibrillar acidic protein (GFAP), rabbit anti-post-synaptic density marker protein 
Synaptosomal preparation
Synaptosomes were obtained from the rat midbrain of cervically dislocated and decapitated adult male Wistar rats as indicated previously ).
All the experiments carried out at the Universidad Complutense de Madrid were performed according to the guidelines of the International Council for Laboratory Animal Science (ICLAS). The isolation procedure differed, depending on the proposed use of the synaptosomal preparation. Synaptosomes used for the determination of [Ca 2+ ] i levels in synaptosomal populations were isolated following the method of Pintor et al. (1992) . Briefly, freshly isolated midbrain was homogenised in 0.32 M sucrose containing 5mM TES and 0.5 mM EDTA, pH 7.4, and centrifuged at 900xg for 5 min. The supernatant was centrifuged at 17000xg for 10 min and the resulting P2 fraction was resuspended in 0.25 M sucrose containing 5mM TES pH 7.4. Protein determination was carried out by the Biuret's method.
Synaptosomes used to estimate [Ca 2+ ] i in single synaptic terminals and those needed for immunocytochemical studies were purified on discontinuous Percoll gradients according to the procedure described by Dunkley et al. (1986) . In brief, P2 fraction was layered on top of a Percoll density gradient composed of 3%, 10% and 23% Percoll prepared in a 1.6 M sucrose medium containing 0.5 M EDTA and 0.1 M DTT. Centrifugation was carried out at 25000xg
for 10 min. Synaptosomes were collected from the 10%/23% Percoll interface, resuspended in This article has not been copyedited and formatted. The final version may differ from this version. ] i increase.
Determining intrasynaptosomal Ca 2+ in synaptosomal populations
Synaptosomal pellets containing 1 mg of protein were re-suspended in 1 mL incubation medium (composition mM: NaCl 122, KCl 3.1, KH 2 PO 4 0.4, NaHCO 3 5, MgSO 4 1.2, glucose 10 and TES buffer 20, pH 7.4). The cytosolic free calcium concentration was determined using Fura-2 as described by Grynkiewicz et al. (1985) . Briefly, five minutes after resuspension, 1.33 mM CaCl 2 and 5 µM Fura-2-AM were added to the synaptosomes.
Following incubation for 25 min, the synaptosomes were pelleted (centrifuged at 15,700xg for 1 min), washed twice and re-suspended in fresh medium containing 1.33 mM CaCl 2 .
Fluorescence was measured in a Perkin Elmer Spectrofluorimeter LS-50, and monitored at λ ex 340 nm and λ em 510 nm. Data were collected at 0.5 s intervals.
Synaptosomes were preincubated for different times (from 30 sec to 6 min) with 100 µM GABA, muscimol (GABA A receptor agonist) or baclofen (GABA B receptor agonist) before assaying Ap 5 A. Once the optimal preincubation time was established, concentrationresponse curves for Ap 5 A and Gp 5 G ranging from 10 -4 to 10 -14 M were obtained in the presence of 100 µM baclofen. As controls, independent concentration-response curves (10 -4 to 10 -6 M) were prepared for Ap 5 A and Gp 5 G.
In some experiments, synaptosomes were preincubated for 2 min with 100 µM saclofen (a GABA B receptor antagonist), 10 µM forskolin (an adenylate cyclase activator) or 100 µM (DiBucAMP) before Ap 5 A application. Since PKA inhibitory peptide (PKA-IP; 25 nM) does not cross the plasma membrane, it was added to the homogenisation buffer during synaptosomal preparation to allow its access to the intrasynaptosomal media (Pintor et al., 1997b) . Finally, preincubation with 10 µM SKF-89976A (a specific GABA-uptake inhibitor) was performed for 2 min before Ap 5 A addition in order to increase the extrasynaptosomal GABA concentration.
Intrasynaptosomal calcium levels are expressed as the mean ± SEM of at least three determinations performed in triplicate in different synaptosomal preparations. Concentrationresponse curves were fitted using Fig P version 
Calcium imaging in single synaptosomes
Synaptosomal pellets containing 0.5 mg of protein were resuspended in 1 mL HBM and loaded with 5 µM Fura-2 AM and 1.33 mM CaCl 2 for 45 min at 37ºC. The synaptosomal suspension was attached to a poly-L-lysine-coted coversplip for 45 min at room temperature.
This time period is sufficient for both sticking on the substrate and hydrolysis of the intrasynaptosomal Fura-2 AM. Next, the cover slips were washed with fresh HBM containing ] i values using the Grynkyevicz's equation (Grynkyevicz et al., 1985) . The variables Rmax, Rmin and β were calculated "in vitro" from the spectra of small Fura-2 droplets in Ca 2+ -saturated solution (composition mM: KCl 100, NaCl 10, MgCl 2 1, Tris 10, MOPS 10, CaCl 2 2 and Fura-2 100 µM) and Ca
2+
-free solution (composition mM: KCl 100, NaCl 10, MgCl 2 1, Tris 10, MOPS 10, CaCl 2 2 and Fura-2 100 µM), both determined empirically in our system. This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Effect of GABA receptor agonists on Ap 5 A calcium responses in rat midbrain nerve terminals
Synaptosomal pellets from rat midbrain were preincubated with 100 µM GABA, baclofen (a selective GABA B receptor agonist) or muscimol (a specific GABA A receptor agonist) for 2 min before the addition of 100 µM Ap 5 A. As previously reported by Gómez-Villafuertes et al. In order to analyse in depth the modulatory effect of presynaptic GABA receptors on Ap 5 A calcium responses, the distribution of these receptors on synaptic terminals was studied using immunocytochemical techniques (Fig. 2) . Antibodies raised against α3 subunit have been extensively employed as markers for GABA A receptors (Benke et al., 1991) . In this way, the absence of immunolabelling against α3 subunit in rat midbrain synaptic terminals correlates well with the lack of effect of muscimol on Ap 5 A calcium responses ( Fig. 2A-C ).
On the contrary, the analysis of roughly 1475 synaptosomes from six fields showed that 62.1 ± 6.9% of them exhibit GABA B receptors ( Fig. 2D-F value of 43.6 ± 7.0 µM and a maximal calcium increase of 28.1 ± 2.6 nM, which corresponds to 100% of the control maximal effect (Fig. 4A) . When synaptosomes were preincubated with This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4A) . The low potency component showed an increase of 52.0 ± 6.2% above the control curve value, changing the maximal Ap 5 A-induced calcium increment from 28.1 ± 2.6 to 42.7 ± 3.4 nM. These results obtained with baclofen, a selective agonist of GABA B receptors, strongly support the involvement of these receptors in the potentiation of Ap 5 A calcium responses.
In control experiments, diguanosine polyphosphates (Gp n G) appears to be as good agonist as Ap n A acting through presynaptic specific dinucleotide receptors in rat midbrain synaptic terminals . To determine whether baclofen could enhance diguanosine polyphosphates effect, Gp 5 G was assayed. The control curve obtained was monophasic with an EC 50 value of 20.8 ± 3.1 µM and a maximal calcium increase of 32.3 ± 3.2 nM, which corresponds to 100% of the control maximal effect (Fig. 4B) . Moreover, the preincubation of synaptosomes with 100 µM baclofen also induced the appearance of a biphasic Gp 5 G concentration-response curve (Fig. 4B) . It is to notice that Hill values observed for the high potency component of Ap 5 A or Gp 5 G concentration-response curves were < 1, whereas Hill numbers obtained for the low potency component were always > 1. However, the biphasic curve for Gp 5 G differed from the two-stepped Ap 5 A concentration-response curve in both, the maximal calcium responses and the affinity of the high potency step. populations it induced no calcium response in the absence of baclofen but evoked a significant effect when synaptosomes were preincubated with the GABA B agonist (Fig. 4A ).
This article has not been copyedited and formatted. The final version may differ from this version. Thus, synaptic terminals mounted in a superfusion chamber, were first challenged with 100 nM Ap 5 A, and then superfused with 100 µM baclofen for 2 min. Successive stimulation was achieved with 100 nM Ap 5 A in the presence of baclofen immediately followed by 100 µM Ap 5 A. As usually, a pulse of 30 mM KCl was applied at the end of each experiment.
The analysis of roughly 2450 synaptosomes from six fields showed that four different populations could be identified according to their response to Ap 5 A. The first group was formed by a significant percentage of synaptosomes that failed to respond to 100 nM Ap 5 A in the absence of baclofen, but responded to this stimulus in its presence (Fig. 5A ). This group represented 16.8 ± 2.9% of the synaptic terminals responding to 30 mM K + , which were always considered as 100% of the total functional synaptosomal population. A second synaptosomal population, accounting for 9.5 ± 3.9% of the total, showed no response to 100
nM Ap 5 A in the presence of baclofen, only responding to 100 µM Ap 5 A (Fig. 5B ). These results indicated that baclofen is able to modulate the effect of low Ap 5 A concentrations in approximately 64% of the synaptosomes responding to high, but not to low, dinucleotide concentrations. It is no notice the presence of a third group of synaptic terminals that showed an intense response to low Ap 5 A concentrations (100 nM) in the absence of baclofen but did not enhance calcium entrance when further stimulated with Ap 5 A (Fig. 5C ). This group represented 16.1 ± 3.1% of the total rat midbrain synaptic terminals. Finally, the fourth population corresponded to synaptic terminals that do not respond to Ap 5 A (data not shown).
The potentiatory effect of baclofen on Ap 5 A calcium responses is mediated by PKA inhibition
In order to corroborate the involvement of GABA B receptors in the potentiation of Ap 5 A calcium responses, we analysed the effect of 100 µM saclofen, a GABA B receptor antagonist.
This compound blocked the potentiatory effect mediated by baclofen, producing an approximate calcium increase of 24.2 nM that corresponds to a percentage of 86.0 ± 12.3% when compared to the control value (Fig. 6 ). The incubation of the synaptosomal preparation with the GABA-uptake inhibitor SKF 89976A (10 µM), which increase the extrasynaptosomal GABA concentration, was able to enhance the Ap 5 A calcium response to 36.2 nM, corresponding to 28.9 ± 7.7% over the control response (Fig. 6) .
Previous results have shown that the activation of GABA B receptors by baclofen mediates a decrease in intracellular cAMP levels in a variety of cell systems, including rat midbrain synaptic terminals . In this way, we adopted two 14 receptors in our model: one was designed to activate and the other to inhibit the activity of this enzyme (Fig. 6 ). PKA activation was indirectly induced using 10 µM forskolin and directly achieved with 100 µM DiBucAMP. As described for saclofen, preincubation of synaptosomes with forskolin or DiBucAMP completely inhibited the potentiatory effect mediated by baclofen, producing calcium increases of 24.5 nM and 26.1 nM respectively, which correspond to values of 87.2 ± 8.5% and 93.1 ± 10.9% when compared to the control (100%). PKA-IP (25 nM) was also assayed to check whether this kinase was implicated in the potentiation observed. This inhibitory peptide enhanced by its own the Ap 5 A calcium response to 38.6 nM, corresponding to an increase of 37.5 ± 6.1% over the control value.
Collectively, these findings are consistent with an inhibitory action of PKA on dinucleotide receptors.
This article has not been copyedited and formatted. The final version may differ from this version. conductance, presumably at N-type channels (Takahashi et al., 1998; Filippov et al., 2000) . The present work provides the first demonstration of a presynaptic interaction between GABA B receptors and ligandgated calcium channels activated by dinucleotides. This result is supported by the broad distribution of metabotropic GABA B receptors in synaptic terminals, in agreement with previous studies (Billinton et al., 2001; Möhler et al., 2001 ). On the contrary, synaptosomes did not show positive inmunostaining against α3 subunit, which is among the most strongly expressed GABA A receptor subunit in the CNS (Benke et al., 1991) , and muscimol has no effect on Ap 5 A calcium responses. Indeed, a presynaptic localisation of GABA A receptors has been only reported in rat suprachiasmatic nucleus (Belenky et al., 2003) . GTP or GDP , the existence of specific dinucleotide receptors equally sensitive to both adenine and guanine dinucleotides is required. The high potency step of Direct phosphorylation processes have been proposed as a regulatory mechanism for different ionotropic neurotransmitter receptors such as nicotinic, GABA A , NMDA, AMPA, P2X and dinucleotide receptors (Swope et al., 1999; Chen and Bobin, 1998; Paukert et al., 2001; Pintor et al., 1997b) . GABA B receptors are negatively coupled to adenylate cyclase (AC), decreasing intracellular cAMP levels when activated. Previous studies in synaptic terminals have demonstrated that the activation of presynaptic GABA B receptors potentiates ATP responses acting through P2X receptors and blocks forskolin-stimulated cAMP formation . Based on these results, it seems reasonable to suggest that a decreased cAMP concentration reduces PKA activity, leading to a lower degree of phosphorylation of the dinucleotide receptor that could modify its affinity for Ap 5 A. It is to notice that the dinucleotide receptor has not been cloned yet, but ionotropic nucleotide receptors, such as P2X 2 , contain phosphorylation sites for PKA in the C-terminal region (Chow and Wang, 1998; Chen and Bobbin, 1998) . To verify the phosphorylation hypothesis, The relevance of the findings here reported relies on the effect of GABA B receptor activation on other variety of ion channels, but this time being ligand-operated Ca 2+ /Na + channels that exhibit a much more restricted distribution. It is particularly relevant the location of ionotropic dinucleotide receptors in aminergic terminals from rat basal ganglia and in midbrain cholinergic and GABAergic terminals (Giraldez et al., 2001; Díaz-Hernández et al., 2002b; Gómez-Villafuertes et al., 2001) . It is to notice that in brain perfusates from neostriatum of conscious rat submitted to strong brain stimulation, the extracellular amounts of dinucleotides increases dramatically, reaching nanomolar concentrations (Pintor et al., 1995) . The longer half -life of dinucleotides compared to ATP made these compounds to be able to exert their effects in more distant areas, inducing presynaptic stimulation when GABA B receptors are activated (Mateo et al., 1997) . It is too early to fully understand the physio-pathological implications of these findings, but they should be taken into account when considering the modulatory actions of GABA B receptors and the regulation of presynaptic ligand-gated ion channels.
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